COMMUNIQUÉS West-GlobeNewswire

-
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
07/11/2017 - 07:05 -
CORRECTION OF PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
07/11/2017 - 07:00 -
Todd Bazemore Steps Down from Role as Chief Operating Officer of Santhera's US Subsidiary
06/11/2017 - 20:36 -
VALNEVA : Déclaration d'actions et de droits de vote octobre 2017
06/11/2017 - 18:00 -
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2017
06/11/2017 - 18:00 -
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2017
06/11/2017 - 18:00 -
Le MABp1 de XBiotech fera l'objet d'une présentation orale lors des séances scientifiques de l'American Heart Association
06/11/2017 - 17:28 -
Ossur Hf : Transactions in relation to share buyback program
06/11/2017 - 17:00 -
Acarix AB to seek new CEO
06/11/2017 - 14:40 -
Adaptimmune marks Official Opening of U.K. Headquarters
06/11/2017 - 14:15 -
Novo Nordisk A/S - Share repurchase programme
06/11/2017 - 13:31 -
Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates
06/11/2017 - 13:30 -
Summit Therapeutics Announces Revenue Sharing Agreement with Wellcome Trust
06/11/2017 - 13:00 -
iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting
06/11/2017 - 13:00 -
Amer Sports Corporation: Managers' transactions
06/11/2017 - 13:00 -
PCI Biotech to present at BIO-Europe 2017
06/11/2017 - 10:32 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
06/11/2017 - 09:00 -
Orphazyme publishes offering circular and the indicative offer price range for its IPO
06/11/2017 - 08:37 -
Silmäasema Oyj: Silmäasema opens new eye clinic in the centre of Oulu
06/11/2017 - 08:00
Pages